Expertise to navigate from molecule to medicine
ICON provides global, robust asset development consulting, to give you a deeper understanding of development options and access to scientific expertise across disciplines for ad hoc support.
With a network of international experts and a customer focused approach, we deliver superior regulatory and quality assurance strategies, submissions, and support to expedite drug and medical device development and manage ongoing global compliance.
ICON has over three decades of experience in advising clients, from molecule to medicine. Our asset development, regulatory consulting, and commercial consultants serve clients around the globe— delivering customized solutions to meet the needs of biotech startups, big pharma and medical device developers —as well as the research, investment, and legal firms that serve them.
Intelligent non-clinical design to expedite development and maximise clinical flexibility
Offering global, robust clinical development consulting to virtual companies, start-ups, biotechs, pharmaceutical, and medical device sponsors.
Demonstrating potential of drug and device candidates.
Proven technical expertise in the design of biologics and small molecule CMC strategy and implementation
Strategies to communicate your product's value to key stakeholders
Expertise and integrated solutions to accelerate market access and drive product adoption
Dedicated medical device and diagnostics experts for all stages of development
Helping clients to navigate complex global regulatory requirements and emerging issues.
It is essential to develop a regulatory strategy plan early in drug development to identify key challenges that may arise, and interact collaboratively with regulatory authorities.
12 January, 2021. Register now.
3 February, 2021. Register today.
Alternative trial models which can include digital health technologies, in-home clinical visits and remote monitoring.
Technologies that accelerate and improve clinical trials.
Watch on-demand webinar recording.
An adaptive design clinical trial can help to create a stronger value proposition for your medical device by reducing development costs and accelerating time-to-market.
Late phase research, technology solutions and access to RWD are at the forefront of creating efficiencies in all stages of study design and implementation
A roadmap to meet 2022 deadlines, while navigating pandemic disruptions